Literature DB >> 21977807

Effects of zuogui pill (see text) on Wnt singal transduction in rats with glucocorticoid-induced osteoporosis.

Mei-Jie Liu1, Yan Li, Jing-Hua Pan, Hong Liu, Shao-Jun Wang, Jing-Ru Teng, Hong-Yan Zhao, Da-Hong Ju.   

Abstract

OBJECTIVE: To reveal the mechanism of Zuogui Pill (see text) in treatment of glucocorticoid-induced osteoporosis from the angle of the Wnt signal transduction pathway and to provide further experimental evidence for expounding the scientific connotation of "the kidney dominating the bones" in TCM.
METHODS: Forty-two male Wistar rats were selected and randomly divided into three groups, control group (n = 12), model group (n = 15) and Zuogui Pill group (n = 15). Form the beginning, The rats were injected dexamethasone for eight weeks to make the model of osteoporosis, and the Zuogui Pill were administered intragastrically to the rats of Zuogui Pill group for eight weeks. The relative morphological parameters were measured in the undecalcified tibial slices. And the protein expression levels of Wnt1, LRP-5 and beta-catenin in rat tibial osteoblasts (OB) and bone marrow stromal cells (BMC) were detected by immunohistochemistry.
RESULTS: Compared with the control group, TBV% and TFS% decreased significantly, while TRS% increased significantly, and the protein expression of Wnt1, LRP-5 and beta-catenin in OB and BMC decreased significantly in the model group. And compared with the model group, TBV% and TFS% increased significantly, and expression levels of Wnt1, LRP-5 and beta-catenin proteins increased significantly in the Zuogui pill group.
CONCLUSION: Zuogui Pill can prevent and treat glucocorticoid-induced osteoporosis in rats by up-regulating the expression of the key signal molecules Wnt1, LRP-5 and beta-catenin in Wnt signal transduction pathway.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21977807     DOI: 10.1016/s0254-6272(11)60020-4

Source DB:  PubMed          Journal:  J Tradit Chin Med        ISSN: 0255-2922            Impact factor:   0.848


  7 in total

1.  Olive oil exhibits osteoprotection in ovariectomized rats without estrogenic effects.

Authors:  Xiaohua Zheng; Huijuan Huang; Xiaobing Zheng; Baoheng Li
Journal:  Exp Ther Med       Date:  2016-03-10       Impact factor: 2.447

2.  Evaluating glucocorticoid administration on biomechanical properties of rats' tibial diaphysis.

Authors:  Mohammadjavad Freidouni; Hossein Nejati; Maryam Salimi; Mohammad Bayat; Abdollah Amini; Mohsen Noruzian; Mohammad Ali Asgharie; Milad Rezaian
Journal:  Iran Red Crescent Med J       Date:  2015-03-31       Impact factor: 0.611

Review 3.  Prevention and Treatment of Osteoporosis Using Chinese Medicinal Plants: Special Emphasis on Mechanisms of Immune Modulation.

Authors:  Hongyan Zhao; Ning Zhao; Peng Zheng; Xiaohong Xu; Meijie Liu; Dan Luo; Huihui Xu; Dahong Ju
Journal:  J Immunol Res       Date:  2018-02-20       Impact factor: 4.818

Review 4.  Mechanisms of Zuogui Pill in Treating Osteoporosis: Perspective from Bone Marrow Mesenchymal Stem Cells.

Authors:  Aofei Yang; Chaochao Yu; Fang You; Chengjian He; Zhanghua Li
Journal:  Evid Based Complement Alternat Med       Date:  2018-09-19       Impact factor: 2.629

5.  Effects of Acupoint Application Therapy with TianGui Powder on Osteoporosis in Ovariectomized Rats through TGF-β1 and Smad2/3 Signaling Pathway.

Authors:  Xiao-Sheng Lin; Hai-Yan Wang; Zhen Zhang; Han-Jiao Liu; Zhen Qu; Ke-Liang Wu; Qing-Hua Xiao; Jian-Zong Zhu; Ping Zhang
Journal:  Orthop Surg       Date:  2019-02       Impact factor: 2.071

Review 6.  Chinese patent medicine for osteoporosis: a systematic review and meta-analysis.

Authors:  Yan Jia; Jigao Sun; Yan Zhao; Kaiqiang Tang; Ruizheng Zhu; Wei Zhao; Rongtian Wang; Yanqiong Zhang; Na Lin; Weiheng Chen
Journal:  Bioengineered       Date:  2022-03       Impact factor: 3.269

7.  Prescription patterns of chinese herbal products for osteoporosis in taiwan: a population-based study.

Authors:  Wei-Tai Shih; Yao-Hsu Yang; Pau-Chung Chen
Journal:  Evid Based Complement Alternat Med       Date:  2012-10-10       Impact factor: 2.629

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.